Virtual Library
Start Your Search
Raymond Osarogiagbon
Moderator of
-
+
11 - Surgically Resectable (ID 11)
- Event: TTLC 2019
- Type: General Session
- Track:
- Presentations: 10
- Moderators:Nasser Altorki, Raymond Osarogiagbon
- Coordinates: 2/22/2019, 08:00 - 09:05, Starlight Ballroom
-
+
Adjuvant Alchemist ALK TKIs (ID 11.06)
08:00 - 09:05 | Author(s): David Gerber
- Abstract
Abstract not provided
-
+
Adjuvant IO (ID 11.05)
08:00 - 09:05 | Author(s): Penelope Bradbury
- Abstract
Abstract not provided
-
+
LCMC4 Umbrella (ID 11.09)
08:00 - 09:05 | Author(s): Jamie Chaft
- Abstract
Abstract not provided
-
+
Neoadjuvant Atezolizumab (LCMC3) and Pembrolizumab (ID 11.02)
08:00 - 09:05 | Author(s): Jay Lee
- Abstract
Abstract not provided
-
+
Neoadjuvant Chemo + Atezolizumab (ID 11.03)
08:00 - 09:05 | Author(s): Catherine Shu
- Abstract
Abstract not provided
-
+
Neoadjuvant Crizotinib ALK ROS and MET (ID 11.08)
08:00 - 09:05 | Author(s): Caroline McCoach
- Abstract
Abstract not provided
-
+
Neoadjuvant Nivolumab +/- Ipilimumab (NEOSTAR) (ID 11.04)
08:00 - 09:05 | Author(s): Tina Cascone
- Abstract
Abstract not provided
-
+
Osimertinib EGFR Mutant (ID 11.07)
08:00 - 09:05 | Author(s): Collin Blakely
- Abstract
Abstract not provided
-
+
Science (ID 11.10)
08:00 - 09:05 | Author(s): David Harpole
- Abstract
Abstract not provided
-
+
Surgery Considerations After IO or TKI (ID 11.01)
08:00 - 09:05 | Author(s): Erin Gillaspie
- Abstract
Abstract not provided